Biomarkers of liver dysfunction correlate with a prothrombotic and not with a prohaemorrhagic profile in patients with cirrhosis.
Fiche du document
- doi: 10.1016/j.jhepr.2020.100120
- issn: 2589-5559
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jhepr.2020.100120
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/32715285
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/2589-5559
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_07141FDF59B04
info:eu-repo/semantics/openAccess , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
Sujets proches
Hemoptysis Bleeding HaemorrhageCiter ce document
M.G. Zermatten et al., « Biomarkers of liver dysfunction correlate with a prothrombotic and not with a prohaemorrhagic profile in patients with cirrhosis. », Serveur académique Lausannois, ID : 10.1016/j.jhepr.2020.100120
Métriques
Partage / Export
Résumé
Different liver dysfunction biomarkers are used to assess the bleeding risk of patients with cirrhosis, either as such or included in bleeding risk assessment scores. Since the current model of coagulation in patients with cirrhosis describes a procoagulant tendency with increasing severity according to Child-Pugh stage, we decided to investigate the relation between liver dysfunction biomarkers and thrombin generation. Our aim was to verify their adequacy for bleeding risk assessment. We performed a prospective single-centre study including 260 patients with liver cirrhosis. Thrombin generation was measured using ST Genesia® Thrombin Generation System without and with thrombomodulin in order to assess the role of proteins C and S. Relations between thrombin generation and Child-Pugh/model for end-stage liver disease (MELD) scores, prothrombin time (PT)/international normalised ratio (INR), activated partial thromboplastin time (aPTT), factor V activity, albumin, and total bilirubin were assessed. Thrombomodulin-mediated inhibition of thrombin generation was significantly decreased in patients with liver cirrhosis compared with healthy donors (p